Medical News

RSS

Appropriate treatment for children with meniscal tears leads to high success rate: Study

The meniscus is a rubber-like, crescent moon-shaped cartilage cushion that sits between the leg and thigh bone. Each knee has two menisci: one on the inside of the knee joint and one on the outside. In recent years, more children have been diagnosed with tears to this area (meniscal tears); however, according to a literature review published in the November 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), prospects for a full recovery are high.

3 Nov 2009

Medico's Hirata to distribute Broncus Technologies' LungPoint system and Yield catheters in Japan

Broncus Technologies, Inc., a medical device company focused on developing and commercializing innovative solutions for lung diseases, announced today at the American College of Chest Physicians CHEST 2009 meeting that it has entered into an exclusive agreement with Medico's Hirata as the sole distributor of their LungPoint system and Yield catheters in Japan.

3 Nov 2009

$Aggressive osteoporosis prevention could reduce hip fracture rate in the U.S. by 25%: Study$

Aggressive osteoporosis prevention could reduce hip fracture rate in the U.S. by 25%: Study

Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.

3 Nov 2009

AMRI receives $750,000 milestone payment from Bristol-Myers Squibb

AMRI announced today that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Company will proceed into preclinical development. AMRI will receive a $750,000 payment from Bristol-Myers Squibb for the completion of this milestone, marking the fifth milestone payment in the ongoing research collaboration between the two companies.

3 Nov 2009

mPhase Technologies receives U.S. patent for "greener" battery technology

mPhase Technologies, Inc. reported today that it has been granted a United States patent for its concept for a battery that is safer for the environment. mPhase's "greener" battery technology could potentially help to reduce the harmful residual chemicals in a battery once it has reached the end of its life and is discarded.

3 Nov 2009

Siemens Healthcare to distribute Candelis' ImageGrid PACS-RT Appliance and ImageGrid RT Viewer

Today, Candelis, Inc. announced its plans to distribute and sell the ImageGrid™ PACS-RT Appliance and the ImageGrid™ RT Viewer through Siemens Healthcare’s Oncology Care Systems Business Unit.

3 Nov 2009

Not enough is being done to support patients suffering from tinnitus

As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.

3 Nov 2009

Skilled Healthcare Group announces unaudited financial results for the third quarter of 2009

Skilled Healthcare Group, Inc. today announced its unaudited consolidated financial operating results for the three- and nine-month periods ended September 30, 2009.

3 Nov 2009

Macomb County Health Department announces H1N1 influenza clinic

Another large community H1N1 influenza clinic has been scheduled by the Macomb County Health Department, the department announced today. It will be held at Freedom Hill County Park in Sterling Heights this Saturday, Nov. 7, from 9 a.m. to 3 p.m. Freedom Hill is located at 14900 Metropolitan Parkway.

3 Nov 2009

Patients with non-small cell lung cancer treated with PCI decrease their risk of developing brain metastases

Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).

3 Nov 2009

Tyco Healthcare violates antitrust laws relating to its Nellcor pulse oximetry products

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that the Ninth Circuit Court of Appeals has affirmed the 2006 Federal District Court decision that Tyco Healthcare, now Covidien, violated the antitrust laws through anticompetitive business practices related to the sale of its Nellcor pulse oximetry products.

3 Nov 2009

MGH Institute of Health Professions 3rd Annual Scholarship Gala generates more than $350,000

More than 350 people packed the Grand Ballroom at the Fairmont Copley Plaza Hotel Thursday, October 29, at the MGH Institute of Health Professions 3rd Annual Scholarship Gala.

3 Nov 2009

AAPM Task Group issues new radiation guidelines for brachytherapy

Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analyzed using post-implant CT or MRI and uniformly documented in every patient, according to a new guideline co-authored by Yan Yu, Ph.D., director of Medical Physics in the department of Radiation Oncology at Thomas Jefferson University.

3 Nov 2009

Tumor-penetrating microparticles may offer treatment hope for those suffering with pancreatic cancer

Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein.

3 Nov 2009

Prasco Laboratories to provide distribution services for generic versions of Allegra-D and Drisdol

Prasco Laboratories announced today that it has entered into agreements with Winthrop U.S., a business of sanofi-aventis U.S., to provide sales support and distribution services to Winthrop U.S. for authorized generic versions of Allegra-D® 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) extended-release tablets and Drisdol® (ergocalciferol) capsules in the United States under the Winthrop label.

3 Nov 2009

Modified version of Bluetooth can transfer patient data four times as fast as conventional Bluetooth

A telemedicine system based on a modified version of the Bluetooth wireless protocol can transfer patient data, such as medical images from patient to the healthcare provider's mobile device for patient assessment almost four times as fast as conventional Bluetooth and without the intermittent connectivity problems, according to a paper in the forthcoming issue of the International Journal of Medical Engineering and Informatics.

3 Nov 2009

Study reveals high risk of recurrence for early-stage breast cancer patients with HER2 positive tumors

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

3 Nov 2009

Tamiflu in short supply, pharmacists compound doses for children suffering from the H1N1 flu virus

Community pharmacists have stepped up to meet the shortage of Tamiflu by compounding doses for children suffering from the H1N1 flu virus, but they are struggling with supply problems and insurance plans, according to the National Community Pharmacists Association.

3 Nov 2009

Crohn's disease drug market driven by TNF-alpha inhibitors Humira and Remicade

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

3 Nov 2009

Cuts in cancer care a move in the wrong direction of health care reform, says COA

The Community Oncology Alliance (COA) today criticized the newest round of cuts in cancer care as a move in the wrong direction of health care reform. Although not as devastating as expected, the cuts by the Centers for Medicare and Medicaid Services (CMS) will still decrease reimbursements far beyond what the U.S. cancer care delivery system, including most patients, can bear.

3 Nov 2009

Medical News

Appropriate treatment for children with meniscal tears leads to high success rate: Study

Medico's Hirata to distribute Broncus Technologies' LungPoint system and Yield catheters in Japan

Aggressive osteoporosis prevention could reduce hip fracture rate in the U.S. by 25%: Study

AMRI receives $750,000 milestone payment from Bristol-Myers Squibb

mPhase Technologies receives U.S. patent for "greener" battery technology

Siemens Healthcare to distribute Candelis' ImageGrid PACS-RT Appliance and ImageGrid RT Viewer

Not enough is being done to support patients suffering from tinnitus

Skilled Healthcare Group announces unaudited financial results for the third quarter of 2009

Macomb County Health Department announces H1N1 influenza clinic

Patients with non-small cell lung cancer treated with PCI decrease their risk of developing brain metastases

Tyco Healthcare violates antitrust laws relating to its Nellcor pulse oximetry products

MGH Institute of Health Professions 3rd Annual Scholarship Gala generates more than $350,000

AAPM Task Group issues new radiation guidelines for brachytherapy

Tumor-penetrating microparticles may offer treatment hope for those suffering with pancreatic cancer

Prasco Laboratories to provide distribution services for generic versions of Allegra-D and Drisdol

Modified version of Bluetooth can transfer patient data four times as fast as conventional Bluetooth

Study reveals high risk of recurrence for early-stage breast cancer patients with HER2 positive tumors

Tamiflu in short supply, pharmacists compound doses for children suffering from the H1N1 flu virus

Crohn's disease drug market driven by TNF-alpha inhibitors Humira and Remicade

Cuts in cancer care a move in the wrong direction of health care reform, says COA

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News